Trials / Not Yet Recruiting
Not Yet RecruitingNCT07069036
A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of SEP-631 in Healthy Adult Volunteers
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Septerna, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-631 in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SEP-631 | Oral, tablet |
| OTHER | Placebo | Oral, tablet |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2026-03-01
- Completion
- 2026-04-01
- First posted
- 2025-07-16
- Last updated
- 2025-07-16
Source: ClinicalTrials.gov record NCT07069036. Inclusion in this directory is not an endorsement.